TrialClinical cancer research : an official journal of the American Association for Cancer Research2013

Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial.

Bryan P Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.